COVID-19
In a potentially disastrous move, President Joe Biden declared the COVID-19 pandemic "over" during a 60 Minutes interview, sparking a heated debate over the implications for his administration's twin goals of student debt relief and coronavirus aid. The remarks have set the stage for a months-long
COVID-19
The European Commission has granted an expanded conditional marketing authorization (CMA) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) as a homologous and heterologous booster for active immunization against COVID-19 in adults aged 18 and older. This approval follows a recommendation made by the European Medicines Agency'
COVID-19
Researchers from the University of Texas MD Anderson Cancer Center have reported a groundbreaking study on oncolytic virotherapy, a form of immunotherapy that uses viruses to target and destroy cancer cells. According to their findings, the COVID-19 pandemic has created a unique opportunity for this type of therapy, as the
COVID-19
During the COVID-19 pandemic, particularly during the lockdown, there has been a significant increase in the frequency and severity of domestic head, neck, and face (HNF) dog bite injuries in children. According to a study published in the Journal of Oral Biology and Craniofacial Research, the COVID-19 pandemic was significantly
COVID-19
Researchers from the Clarity Movement Co. have conducted a study examining the impact of the Intercontinental Terminals Company (ITC) fire and COVID-19 on airborne particulate matter (PM) concentrations in communities in Houston. The study, published in the journal Science of The Total Environment, used a network of low-cost sensors to
COVID-19
Research conducted at the University of California San Francisco (UCSF) has provided new insights into the transplacental transfer of mRNA vaccine products and functional SARS-CoV-2 antibodies during pregnancy and early infancy. This study aimed to evaluate the levels of protection provided to newborns through placental transfer of antibodies. The findings
COVID-19
The Mehilainen Airport Health Centre in Vantaa, Finland, has published a report highlighting the importance of alternative statin use for COVID-19 patients with hypercholesterolemia who are taking Paxlovid. According to the research, the concomitant use of Paxlovid and a statin may result in significant drug interactions, making it essential to
COVID-19
Researchers from the University of California, Berkeley, have conducted a comprehensive study to understand the interactions between the SARS-CoV-2 virus and human host factors. The study, published in Nature Genetics, utilized genome-wide CRISPR knockout and activation screens in human lung epithelial cells to identify host factors that influence viral infection.
COVID-19
The global Blockchain AI market is witnessing unprecedented growth, driven by the increasing adoption of Blockchain solutions enabled by artificial intelligence (AI) to combat the COVID-19 pandemic. International and regional agencies are leveraging the capabilities of Blockchain AI to efficiently collect, analyze, store, and monitor data related to the coronavirus.
COVID-19
A recent study from the University of California San Francisco (UCSF) has shed light on why children are less likely to suffer severe disease from SARS-CoV-2, the virus responsible for COVID-19, compared to older adults. Researchers investigated the upper airway immune response in 83 children and found that they exhibit
COVID-19
Research by the Southwest University of Science and Technology has led to the development of a blockchain-based solution to facilitate global travel during the COVID-19 pandemic and future pandemics. The solution, called Borderless, aims to address the limitations of current travel restrictions by providing a secure and adaptive proof protocol
COVID-19
Polio, an infectious disease that was largely eradicated in Canada nearly three decades ago, has re-emerged in some western nations, sparking concerns about a potential outbreak in Canada. Despite widely available and effective vaccines against the illness, disruptions from the COVID-19 pandemic and vaccine hesitancy have left some Canadians vulnerable
